VMI
VHCP Management II Portfolio holdings
AUM
$379M
This Quarter Return
-17.04%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$262M
AUM Growth
+$262M
(-17%)
Cap. Flow
+$19.2M
Cap. Flow
% of AUM
7.31%
Top 10 Holdings %
Top 10 Hldgs %
88.78%
Holding
24
New
3
Increased
1
Reduced
5
Closed
3
Top Buys
1 |
10x Genomics
TXG
|
$90M |
2 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$1.14M |
3 |
RDUS
Radius Health, Inc.
RDUS
|
$352K |
4 |
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
|
$32K |
Top Sells
1 |
Ascendis Pharma
ASND
|
$26M |
2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$17.3M |
3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$10.4M |
4 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$9.56M |
5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$7.63M |
Sector Composition
1 | Healthcare | 98.23% |